• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    New to The Street Announces Episode 590, Five Corporate Interviews, Airing on the Fox Business Network, Tonight Monday, August 19, 2024, at 10:30 PM PT

    8/19/24 9:20:00 AM ET
    $ACXP
    $LRHC
    $ZAPP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate
    Finance
    Get the next $ACXP alert in real time by email

    NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- FMW Media's New to The Street, a national business TV show, announces episode 590, airing on the FOX Business Network, tonight Monday, August 19, 2024, at 10:30 PM PT.

    New to The Street's 590th episode line-up features the following five (5) Corporate interviews:

    1). Two-Wheel Electric Vehicle (EV) - Zapp Electric Vehicles Group Limited's (NASDAQ:ZAPP) ($ZAPP) Mark Kobal, Head of Investor Relations.

    2). Biopharmaceutical - Acurx Pharmaceuticals, Inc.'s (NASDAQ:ACXP) ($ACXP) David Luci, President/CEO.

    3). Real Estate - La Rosa Holdings Corp's. (NASDAQ:LRHC) ($LRHC) Joe La Rosa, Founder/CEO, and Deana La Rosa, Chief Operating Officer.

    4). Sustainable Solutions - The Sustainable Green Team, Ltd.'s (OTC:SGTM) ($SGTM) Tony Raynor, CEO and Founder.

    5). "Sekur Privacy & Sekur Security – The Weekly Hack" segment with internet privacy expert Alain Ghiai, CEO, Sekur Private Data, Ltd. (OTCQB:SWISF) (CSE:SKUR) (FRA: GDT0) ($SWISF) (Sekur®).

    Episode 590

    From the Nasdaq MarketSite Studio, Zapp Electric Vehicles Group Limited's (NASDAQ:ZAPP) ($ZAPP) ("Zapp") Mark Kobal, Head of Investor Relations, is with New to The Street's TV Host Jane King. Zapp is on a mission to redefine the electric two-wheeler segment, and its i300 is an electrified urban two-wheeler capable of motorcycle performance levels that are easy to use and ride. Customers can personalize their i300 and order online with delivery to the home or office by "Zappers," who also provide onsite customer support. Mark discusses the vast global two-wheeler market, approximately $130 billion, primarily outside the US. The i300 incorporates the clean energy benefits of an electric vehicle and provides an affordable solution for personal mobility, including in places lacking sufficient public transportation infrastructure. While the use case for electric cars may require a network of charging stations, two-wheelers are better suited for electrification in urban settings, and the i300 comes with removable, portable batteries that can be charged from any standard wall socket. This avoids any need for dedicated charging infrastructure, and riders can easily incorporate this battery charging into their daily routine, just like laptops and other mobile devices. The technologically advanced i300 is an award-winning and patented design that people want to buy. The on-screen QR code is available during the show; download or visit Zapp Electric Vehicles Group Limited - https://zappev.com/.

    From the Nasdaq MarketSite Studio, New to The Street's TV Host Jane King talks with David Luci, the President/CEO of Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) ($ACXP) ("Company"), a late-stage biopharmaceutical Company that publicly trades on the NASDAQ market. ACXP is developing a new class of small molecular antibiotics for the most common life-threatening bacterial infections. Recently, the Company completed its FDA Phase 2 clinical trials on its Ibezapolstat drug, a treatment for patients with Clostridioides difficile Infections (CDI). Management is now meeting with the FDA regarding the steps necessary to complete the Phase 3 clinical trial on the drug. Concurrently, ACXP is meeting with the FDA on the manufacturing processes of the drug, which needs to meet the government's standards. Management remains confident that Ibezapolstat can be manufactured and inventoried before the conclusion of 2024. The United States Patent and Trademark Office (USPTO) has issued a patent because the drug can, in treated patients, maintain and restore microbiome bacteria. Most pharmaceuticals destroy the gut's microbiome bacteria which is the major cause of diseases and reinfections, typically from competitor drugs for CDI. The issued patent remains valid until June 2042. The Company is working globally with several entities seeking partnerships and other collaborations on non-dilutive financing arrangements for the funding needs of the FDA Phase 3. The objective is to get funded without using ACXP's stock, which will not dilute shareholders' value. David started a program to work with college students, being a mentor to assist students in bringing their scientific ideas to market. Upon successful FDA approval, management expects to proceed with necessary approvals with the European Medicines Agency (EMA). With the FDA and USPTO continuing to provide timely approvals, the Company has shown that its Ibezapolstat drug effectively treats CDI with no reinfections. The on-screen QR code is available during the show; download or visit Acurx Pharmaceuticals, Inc. - https://www.acurxpharma.com/.

    Joe La Rosa, Founder and CEO, and Deana La Rosa, Chief Operating Officer of La Rosa Holdings Corp. (NASDAQ:LRHC) ($LRHC) ("Company") are at the Nasdaq MarketSite studio with New to The Street's TV Host, Jane King. The Company provides real estate brokerage services for residential and commercial properties while utilizing proprietary technology platforms to assist its sales and franchise agents. Because the Company has a disruptive revenue share model that is 100% commission-free, many new agents joined the LRHC, making June 2024 a record month for recruits. La Rosa Realty's unique brokerage model is agent-centric, whereas management wants to ensure each agent has the tools, training, and support to succeed. With several B2B real-estate opportunities in conjunction with the Company's proprietary "JAMIE" AI technology platform, agents have access to multiple revenue sources that don't exist at the typical real-estate offices. The Company currently has around 2,400 agents and expects to have around 4,000 before the end of 2024. Joe and Deana discuss the new offices open in Houston, Texas, Tampa, Florida, and its operations in Georgia, and progress on acquisitions. The Company is now "Beta" testing its latest technology platform, "My Agent Account," which can give agents a full-digital portal for numerous transactional needs, an efficient paperless solution. La Rosa sees an increase in refinancing since the lowering of mortgage rates and expects to see even more real-estate growth as interest cuts could occur in the upcoming months. Real estate is interest rate sensitive; as rates come down, refinancing and buyers/sellers of homes become more in demand. LRHC is growing its operations through its agent-centric base and from accretive solid organic growth. The Company continues to evaluate well-suited acquisitions that are consistent with the Company's business model. The on-screen QR code is available during the show; download or visit La Rosa Holdings Corp. - https://larosaholdings.com/.

    The Sustainable Green Team, Ltd.'s (OTCQX:SGTM) ($SGTM) ("Company")Tony Raynor, CEO, and Founder, is with New to The Street's TV Host Jane King. Talking about the Company from the Nasdaq MarketSite Studio, viewers get an insight into SGTM's environmentally sustainable solutions. Tony informs viewers about the Company's partnership with Jimmy Houston, founder of Jimmy Houston Outdoors, a TV Host, and a Social Media influencer, who has an extensive media and online network and is known for product and service endorsements. With millions of followers and a highly rated show on ESPN, Jimmy always promotes a sustainable agenda to protect fish and wildlife. SGTM and Jimmy will work together to promote SGTM's sustainable product lines and offer a platform for SGTM to launch new goods and services. SGTM creates, produces, and sells sustainable, chemical-free products by converting waste into high-value, nutrient-rich products. New products forthcoming will focus on the health and well-being of livestock and wildlife. Jimmy offers SGTM a platform to endorse current and future products. Tony informs viewers that the Company is producing a media program that will air on Bloomberg TV as a "Bloomberg Original" series. The show will focus on global problems, educating many on how sustainable solutions can restore and replenish the Earth. Influential leaders and businesspeople will be on the show, highlighting current global environmental concerns and the solutions available to make people, plants, and animals healthier; a healthy planet makes for healthy inhabitants. SGTM is soon rolling out new product lines, becoming available at "Big Box" retailers. The Company has a YouTube channel with many informative videos about the Company and its sustainable initiatives and products. The on-screen QR code is available during the shows: The Sustainable Green Team, Ltd. - https://www.thesustainablegreenteam.com/.

    New to The Street airs its "Sekur Privacy & Sekur Security – The Weekly Hack" segment. Alain Ghiai, an internationally acclaimed internet privacy expert and the CEO of Sekur Private Data, Ltd. (OTCQX:SWISF) (CSE:SKUR) (FRA: GDT0) ($SWISF) (Sekur®) talks with TV Host and Multi-media Journalist Ana Berry about another hack at AT&T. It appears that hackers stole at least six months of its customers' calls and text message records. AT&T used a 3rd party cloud base database to store these records, which became compromised. Unfortunately, five to seven of the largest technology companies control the world's data storage and transmissions. One of those is CrowdStrike, which recently had a significant outage, shutting down thousands of its customers access to programs and data. Delta Airlines was virtually shut down because of the CrowdStrike program failure. Sekur is different, providing close-loop access with military encrypted programs on the Company's own and controlled servers in Switzerland. Individuals, businesses, and governmental agencies can all benefit from subscribing to Sekur. To avoid cyberhackers' attempts, subscribers send information through the Company's SekurVPN, SekurMail, and SekurMessenger services, giving end-users private and secure electronic communications. SekurMail, with SekurSend/SekurReply options, sends a link to a recipient to open an email in the closed loop encrypted military platform. The service protects both the subscriber and the recipient, even if the recipient is not a Sekur subscriber. SekurMessenger offers many secure options that prevent text messages from appearing on open BIG Tech platforms. Using SekurMail with the Company's SekurVPN adds another layer of encryption that protects its subscribers' IP addresses and website traffic information. Any entity under regulatory scrutiny can comply with Sekur services. The services are available through iOS and Android apps, and those not interested in downloading apps can use the Company's web-based platforms. Alan states that being more invisible on the net and shrinking your cybersecurity footprint should most likely lessen the chances of becoming a hacked victim. Under Swiss law, your IP address is private property protected by stringent regulations. The Company never tracks your devices, never sells data, doesn't use 3rd party platforms, never asks for phone numbers, and keeps one's internet traffic private and secure. PROMO CODE: PRIVACY is now available, giving 15% savings toward monthly and yearly subscriptions, and the discount will remain active for five years. Viewers, please tune in next time for the newest cybersecurity topic on the "Sekur Privacy & Sekur Security– Weekly Hack" segment. The on-screen QR code is available during the shows to download more info or visit Sekur Private Data, Ltd. – https://sekurprivatedata.com/, http:/sekur.com/ and https://sekur.com/en/vpn. Privacy has arrived!

    About Zapp Electric Vehicles Group Limited (NASDAQ:ZAPP) ($ZAPP):

    Zapp EV (NASDAQ:ZAPP) ($ZAPP) and its operating subsidiaries are run by a team of experts from the mobility industry on a mission to redefine the electric two-wheeler segment. Zapp's debut product, the i300, is an urban electric high-performance two-wheeler capable of traditional motorcycle performance levels in a step-through format, combining ease of use with exhilaration and fun. The i300 is the first in a high-performance electric two-wheeler suite that Zapp plans to bring to market. Zapp will offer a high-quality direct-to-customer experience known as DSDTC (drop-ship-direct-to-customer). Customers ordering the i300 online will have their bikes conveniently delivered to their homes by authorized "Zappers," who will provide at-home inspection, service, and support throughout the vehicle ownership lifecycle. Zapp is a registered Zapp Electric Vehicles Limited trademark in the United Kingdom and other countries. For more information, visit www.zappev.com.

    About Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) ($ACXP):

    Acurx Pharmaceuticals, Inc.(NASDAQ:ACXP) ($ACXP) is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. The Company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS®) that blocks the active site of the Gram-positive specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that target Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), and drug-resistant Streptococcus pneumoniae (DRSP) - https://www.acurxpharma.com/.

    About La Rosa Holdings Corp. (NASDAQ:LRHC) ($LRHC):

    La Rosa Holdings Corp. (NASDAQ:LRHC) ($LRHC) is disrupting the real estate industry by offering agents a choice between a revenue share model or an annual fee-based model with 100% agent commissions. Leveraging its proprietary technology platform, La Rosa empowers agents and franchisees to deliver top-tier service to their clients. The Company provides residential and commercial real estate brokerage services and offers technology-based products and services to its sales and franchise agents. La Rosa's business model is structured around internal services for agents and external services for the public, including residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The Company has 22 La Rosa Realty corporate real estate brokerage offices and branches located in Florida, California, Texas, and Georgia. The Company also has 15 La Rosa Realty franchised real estate brokerage offices and branches and two affiliated real estate brokerage offices in the United States and Puerto Rico - https://larosaholdings.com/.

    About Sustainable Green Team, Ltd. (OTC:SGTM) ($SGTM):

    Sustainable Green Team, Ltd. (OTC:SGTM) ($SGTM) is a leading Company in climate reversing technologies, a provider of sustainable solutions to improve environmental health, promote sustainable practices, and deliver eco-friendly products and services. SGTM aims to make significant contributions to global sustainability; learn more by visiting the Company website, https://thesustainablegreenteam.com/, SGTM's YouTube Channel, Corporate Bloomberg TV commercial - https://www.youtube.com/watch?v=d_0rLESvJJ0, corporate video - https://www.youtube.com/watch?v=xJ7Dp9Coi88&t=1s and SGTM's Blogs - https://thesustainablegreenteam.com/sgtm-blog.

    About Sekur Private Data Ltd. (OTCQB:SWISF) (CSE:SKUR) (FRA: GDT0) ($SWISF):

    Sekur Private Data, Ltd. (OTCQB:SWISF) (CSE:SKUR) (FRA: GDT0) ($SWISF) is a cybersecurity and internet privacy provider of Swiss-hosted solutions for secure communications and secure data management. The Company distributes a suite of secure cloud-based storage, disaster recovery, document management, encrypted emails, and secure communication tools. It sells its products through its websites, www.sekur.com, approved distributors, and telecommunication companies worldwide. Sekur Private Data, Ltd. serves consumers, businesses, and governments worldwide - https:/sekurprivatedata.com and https://sekur.com; Twitter: @sekurprivate.

    About New to The Street:

    New to The Street is an FMW Media production that operates one of the longest-running US and International sponsored and syndicated Nielsen-rated programming television brands, "New to The Street." Since 2009, New to The Street has run biographical interview segment shows across major U.S. television networks. The Nielsen-rated and sponsored broadcast programming platform reaches millions of homes in the US and international markets. FMW's New to The Street show appears on Bloomberg and the FOX Business Network as sponsored programming. FMW is also one of the nation's largest buyers of linear television, long and short-form paid programming - https://newtothestreet.com/.

    Forward-Looking Statements Disclaimer US/Canada:

    This press release contains forward-looking statements within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology. However, not all forward-looking statements contain these words. Forward-looking statements do not guarantee future performance or results and will not necessarily be accurate indications of when such performance or results are achieved. This press release should be considered in all companies' filings contained in the Edgar Archives of the Securities and Exchange Commission at www.sec.gov.

    This press release contains forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking information is often, but not always, identified by the use of words such as "seek," "anticipate," "believe," "plan," "estimate," "expect," "likely," and "intend" and statements that an event or result "may," "will," "should," "could" or "might" occur or be achieved and other similar expressions. These statements reflect management's current beliefs and are based on information currently available to management as of the date hereof. Forward-looking information in this press release includes, without limiting, the foregoing expectations. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

    CONTACT:

    New to The Street

    Monica Brennan

    [email protected]

    https://newtothestreet.com/

    1-917-330-2564

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/7bf7eadd-9176-44bd-a690-e4671fa36096



    Primary Logo

    Get the next $ACXP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACXP
    $LRHC
    $ZAPP

    CompanyDatePrice TargetRatingAnalyst
    Acurx Pharmaceuticals Inc.
    $ACXP
    11/29/2021$12.00Buy
    Maxim Group
    More analyst ratings

    $ACXP
    $LRHC
    $ZAPP
    SEC Filings

    View All

    La Rosa Holdings Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - La Rosa Holdings Corp. (0001879403) (Filer)

    4/6/26 8:30:33 AM ET
    $LRHC
    Real Estate
    Finance

    Amendment: SEC Form NT 10-K/A filed by La Rosa Holdings Corp.

    NT 10-K/A - La Rosa Holdings Corp. (0001879403) (Filer)

    4/1/26 4:12:23 PM ET
    $LRHC
    Real Estate
    Finance

    SEC Form NT 10-K filed by La Rosa Holdings Corp.

    NT 10-K - La Rosa Holdings Corp. (0001879403) (Filer)

    3/31/26 4:05:17 PM ET
    $LRHC
    Real Estate
    Finance

    $ACXP
    $LRHC
    $ZAPP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Hrt Financial Lp bought $15,605 worth of Class A Shares (14,584 units at $1.07) and sold $9,121 worth of Class A Shares (8,368 units at $1.09), increasing direct ownership by 15% to 48,596 units (SEC Form 4)

    4 - La Rosa Holdings Corp. (0001879403) (Issuer)

    3/3/26 2:57:47 PM ET
    $LRHC
    Real Estate
    Finance

    CEO, interim CFO La Rosa Joseph bought $1,146,000 worth of shares (150,000 units at $7.64) (SEC Form 4)

    4 - La Rosa Holdings Corp. (0001879403) (Issuer)

    7/21/25 5:24:04 PM ET
    $LRHC
    Real Estate
    Finance

    Director Scodari Joseph C bought $25,000 worth of shares (24,631 units at $1.01), increasing direct ownership by 800% to 27,708 units (SEC Form 4)

    4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)

    1/8/25 4:32:30 PM ET
    $ACXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACXP
    $LRHC
    $ZAPP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Maxim Group initiated coverage on Acurx Pharmaceuticals with a new price target

    Maxim Group initiated coverage of Acurx Pharmaceuticals with a rating of Buy and set a new price target of $12.00

    11/29/21 8:33:36 AM ET
    $ACXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACXP
    $LRHC
    $ZAPP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    La Rosa Holdings Adds Over $6.4 Million in Net Assets to Balance Sheet as Part of Digital Asset Treasury to Scale AI Infrastructure Strategy

    Celebration, FL, March 31, 2026 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ:LRHC) ("La Rosa" or the "Company"), a real estate and PropTech enterprise, today announced that it has added over $6.4 million, net assets to its balance sheet as part of its digital asset treasury strategy in Q1 of 2026, establishing a strategic reserve to support its expansion into artificial intelligence ("AI") infrastructure and next-generation real estate assets. The strategic reserve, consisting of approximately $8.1 million of digital assets (including approximately $3.9 million restricted under a token rights agreement with the Company's investor) and approximately $2.2 million in cash, is designed

    3/31/26 8:00:00 AM ET
    $LRHC
    Real Estate
    Finance

    Korean Patent Office Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors

    STATEN ISLAND, N.Y., March 30, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult‑to‑treat bacterial infections, today announced that the Korean Intellectual Property Office (KIPO) has granted a new patent which covers DNA Polymerase IIIC inhibitors including compositions‑of‑matter, methods of use, and pharmaceutical compositions, which further strengthen Acurx's intellectual property portfolio and represents the most recent addition to its expanding series of granted patents in the U.S. and abroad. To date, Acurx has secured four U.S. patents, alo

    3/30/26 7:01:00 AM ET
    $ACXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update

    STATEN ISLAND, N.Y., March 13, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today certain financial and operational results for the full year and fourth quarter ended December 31, 2025. Highlights of the fourth quarter ended December 31, 2025, or in some cases shortly thereafter, include:In October 2025, the Company received gross proceeds from the exercise of 170,068 Series F Warrants of approximately $1.4 million.Also in October 2025, we were one of five companies to make a formal presentation at IDWeek in Atlanta

    3/13/26 7:01:00 AM ET
    $ACXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACXP
    $LRHC
    $ZAPP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Cosculluela Jaime Jose

    3 - La Rosa Holdings Corp. (0001879403) (Issuer)

    3/11/26 4:01:02 PM ET
    $LRHC
    Real Estate
    Finance

    Large owner Hrt Financial Lp bought $15,605 worth of Class A Shares (14,584 units at $1.07) and sold $9,121 worth of Class A Shares (8,368 units at $1.09), increasing direct ownership by 15% to 48,596 units (SEC Form 4)

    4 - La Rosa Holdings Corp. (0001879403) (Issuer)

    3/3/26 2:57:47 PM ET
    $LRHC
    Real Estate
    Finance

    New insider Hrt Financial Lp claimed ownership of 56,964 units of Class A Shares (SEC Form 3)

    3 - La Rosa Holdings Corp. (0001879403) (Issuer)

    3/3/26 2:47:42 PM ET
    $LRHC
    Real Estate
    Finance

    $ACXP
    $LRHC
    $ZAPP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Acurx Pharmaceuticals Inc. (Amendment)

    SC 13G/A - Acurx Pharmaceuticals, Inc. (0001736243) (Subject)

    2/14/24 2:39:21 PM ET
    $ACXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by La Rosa Holdings Corp.

    SC 13G - La Rosa Holdings Corp. (0001879403) (Subject)

    1/17/24 4:05:09 PM ET
    $LRHC
    Real Estate
    Finance

    SEC Form SC 13G filed by Acurx Pharmaceuticals Inc.

    SC 13G - Acurx Pharmaceuticals, Inc. (0001736243) (Subject)

    2/14/23 11:59:03 AM ET
    $ACXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACXP
    $LRHC
    $ZAPP
    Leadership Updates

    Live Leadership Updates

    View All

    $ACXP
    $LRHC
    $ZAPP
    Financials

    Live finance-specific insights

    View All

    La Rosa Holdings Corp. Announces Appointment of Nicholas Adler as Chairman of the Board and Chairman of the Compensation Committee

    Celebration, FL, Dec. 30, 2025 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) ("La Rosa" or the "Company"), a real estate and PropTech company, today announced that the Company's Board of Directors (the "Board") has appointed Mr. Nicholas Adler as a member of the Board, effective December 29, 2025. Upon his appointment, Mr. Adler was also named Chairman of the Board, Chairman of the Compensation Committee, and a member of both the Audit Committee and the Nominating and Corporate Governance Committee. Additionally, on December 29, 2025, Mr. Siamack Alavi notified the Board of his resignation as a director of the Company, effective immediately. Mr. Alavi also stepped down from hi

    12/30/25 8:30:00 AM ET
    $FRGT
    $LRHC
    Professional Services
    Consumer Discretionary
    Real Estate
    Finance

    Zapp EV Appoints Authorised Reseller in Ireland

    LONDON, April 29, 2025 (GLOBE NEWSWIRE) -- Zapp Electric Vehicles Group Limited (NASDAQ:ZAPP) ("Zapp EV" or the "Company"), owner of "Zapp", the British electric vehicle brand on a mission to revolutionise personal urban mobility, today announced it has appointed Michael Grant Zapp Limited as its first authorised reseller in Ireland, based in Dublin. Mr. Michael Grant brings more than 40 years of experience in automotive retail businesses to this newly-formed venture dedicated to the sale and support of electric vehicles. David McIntyre, Chief Operating Officer of Zapp EV, said: "We are excited to start working with our first Irish authorised reseller following recent European homologatio

    4/29/25 7:05:00 AM ET
    $ZAPP
    Motor Vehicles
    Consumer Discretionary

    Zapp EV Appoints Its First Authorised Reseller in Europe

    LONDON, March 31, 2025 (GLOBE NEWSWIRE) -- Zapp Electric Vehicles Group Limited (NASDAQ:ZAPP) ("Zapp EV" or the "Company"), owner of "Zapp", the British electric vehicle brand on a mission to revolutionise personal urban mobility, today announced it has appointed Green Mopeds Ltd. ("Green Mopeds") as its first authorised reseller of Zapp's urban electric motorcycle, i300, throughout Great Britain. Customers will be able to see i300 on display and arrange for test-rides from the Green Mopeds location in West London. In addition, Green Mopeds will provide delivery and after-sales support utilising Zapp's proprietary drop-ship-direct-to-customer premium service model.  Zapp anticipa

    3/31/25 6:05:00 AM ET
    $ZAPP
    Motor Vehicles
    Consumer Discretionary

    Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update

    STATEN ISLAND, N.Y., March 13, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today certain financial and operational results for the full year and fourth quarter ended December 31, 2025. Highlights of the fourth quarter ended December 31, 2025, or in some cases shortly thereafter, include:In October 2025, the Company received gross proceeds from the exercise of 170,068 Series F Warrants of approximately $1.4 million.Also in October 2025, we were one of five companies to make a formal presentation at IDWeek in Atlanta

    3/13/26 7:01:00 AM ET
    $ACXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    La Rosa Holdings Acquires Remaining 49% Interest in Profitable Brokerage with $5.1M Trailing Twelve Months Revenue

    Celebration, FL, Feb. 18, 2026 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ:LRHC) ("La Rosa" or the "Company"), a real estate and PropTech enterprise, today announced that it has acquired the remaining 49% ownership interest in its franchisee, La Rosa Realty Lakeland LLC (doing business as La Rosa Realty Prestige) ("Prestige"). With this transaction, Prestige is now a wholly owned subsidiary of La Rosa. Prestige operates in Lakeland, Florida, with an additional branch office in Winter Haven, serving the broader Central Florida market. For the last 12 months, Prestige ranked third as a real estate brokerage based on its agent count and on its total real estate sales volume in Polk Cou

    2/18/26 8:00:00 AM ET
    $LRHC
    Real Estate
    Finance

    Acurx Pharmaceuticals to Discuss Full Year and Fourth Quarter 2025 Financial Results on March 13, 2026 Conference Call and Provide Business Update

    STATEN ISLAND, N.Y., Feb. 16, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that the Company will discuss its full year and fourth quarter 2025 financial results on Friday, March 13, 2026 at 8:00 am ET before the U.S. financial markets open. David P. Luci, President and Chief Executive Officer, and Robert G. Shawah, Chief Financial Officer, will host a conference call to discuss the results and provide a business update as follows:Date:                           Friday, March 13, 2026  Time:                     

    2/16/26 8:01:00 AM ET
    $ACXP
    Biotechnology: Pharmaceutical Preparations
    Health Care